TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ: TMDX ) with a Buy and maintains $120 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.